Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 1, 2020
Salt Lake City, Utah – May 1, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Apr 20, 2020
Salt Lake City, Utah – April 20, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced...
-
Apr 16, 2020
Salt Lake City, Utah – April 16, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,
-
Apr 14, 2020
Salt Lake City, Utah – April 14, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,
-
Apr 6, 2020
Salt Lake City, Utah – April 6, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced...
-
Mar 31, 2020
Salt Lake City, Utah – March 31, 2020 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Mar 20, 2020Company accelerates U.S. sales of COVID-19 test pursuant to new FDA policy
Salt Lake City, Utah – March 19, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced...
-
Mar 19, 2020
Salt Lake City, Utah – March 19, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced...
-
Mar 17, 2020
Salt Lake City, Utah – March 17, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced...
-
Mar 12, 2020
***UPDATE*** Due to travel restrictions and health concerns, the conference has been canceled. We will post any further updates here. Salt Lake City, Utah – March 12, 2020 – Co-Diagnostics,...
-
Mar 5, 2020
Salt Lake City, Utah – March 5, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced...
-
Mar 3, 2020
Salt Lake City, Utah – March 2, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests and that...
-
Mar 2, 2020
Salt Lake City, Utah – March 02, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, today...
-
Feb 27, 2020
Salt Lake City, Utah – February 27, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, today...
-
Feb 24, 2020Logix Smart™ COVID-19 Test now available for export from the United States as a CE-marked IVD
Salt Lake City, Utah – February 24, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Feb 20, 2020Company’s new Logix Smart™ COVID-19 Test expected to be available with CE marking in February 2020
Salt Lake City, Utah – February 20, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Feb 19, 2020
Salt Lake City, Utah – February 19, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Feb 13, 2020
Salt Lake City, Utah – February 13, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Feb 13, 2020
Salt Lake City, Utah – February 13, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, today...
-
Feb 11, 2020
Salt Lake City, Utah – February 11, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, today...
-
Feb 10, 2020
Salt Lake City, Utah – February 10, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Feb 6, 2020Product launch and rapid development of the Logix Smart™ 2019-nCoV coronavirus test facilitated by Company’s proprietary technology platform
Salt Lake City, Utah – February 6, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Feb 4, 2020Coronavirus assay will be addressed in webinar, as well as development of an innovative multiplex application of Company’s technology for mosquito populations
Salt Lake City, Utah – February 4, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Jan 31, 2020Components of recently designed novel coronavirus assay have successfully passed initial verification
Salt Lake City, Utah – January 30, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Jan 30, 2020Co-Diagnostics Inc CEO Interviewed on Fox Business with Maria Bartiromo as Coronavirus Concerns RiseInterviews on Fox Business and other programs discussed issues surrounding the novel strain of the coronavirus and the Company’s plan to provide a diagnostic solution
Salt Lake City, Utah – January 30, 2020 – The CEO of Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic...